Standard Lithium to Attend Upcoming Industry Conferences
May 29, 2024 16:05 ET
|
Standard Lithium
VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium...
Kura Oncology to Participate in Jefferies Global Healthcare Conference
May 29, 2024 07:30 ET
|
Kura Oncology, Inc.
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment...
Steelworkers head into fourth week of strike, call on SNOLAB to bargain fair contract
May 28, 2024 09:15 ET
|
United Steelworkers union
Steelworkers head into fourth week of strike, call on SNOLAB to bargain fair contract.
Incorta launches the first Operational GenAI with leading RAG and LLM providers
May 28, 2024 09:12 ET
|
Incorta, Inc.
FOSTER CITY, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Incorta, a leading operational lakehouse, today announces the launch of Operational GenAI, an unlimited and enterprise GenAI solution built on...
Microplastics and human health: scientist sets record straight
May 28, 2024 08:38 ET
|
International Bottled Water Association
Alexandria, VA, May 28, 2024 (GLOBE NEWSWIRE) -- Common myths about the environmental impact of plastic and concerns about microplastics on human health are debunked by an independent scientist in...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
May 25, 2024 06:15 ET
|
Novartis Pharma AG
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
May 25, 2024 06:00 ET
|
Novartis Pharma AG
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical...
Science World’s Creative Technology Gallery Wins Prestigious CASC Award for Innovation, Leadership and Impact in Making Science Accessible
May 24, 2024 11:00 ET
|
Science World
Vancouver, BC, May 24, 2024 (GLOBE NEWSWIRE) -- Science World is pleased to share that its Creative Technology Gallery, co-presented by Beedie and RBC, has won an award at this year’s Canadian...
Purespring Therapeutics presents preclinical data at the 61st ERA Congress
May 24, 2024 10:57 ET
|
Purespring Therapeutics
Purespring Therapeutics presents preclinical data at the 61st ERA Congress Data establishes the potential of AAV gene therapy to deliver transgenes to the podocyte to replace defective genes or to...